Liang Jin
- Molecular Biology top 5%
- Cancer Research top 5%
- Surgery top 10%
- Biomaterials top 5%
- Oncology top 10%
- Topics
- Pancreatic function and diabetes (14 papers)Diabetes and associated disorders (8 papers)MicroRNA in disease regulation (8 papers)
- Partner nations
- ChinaUnited StatesSpain
In The Last Decade
Liang Jin
93 papers receiving 2.6k citations
Hit Papers
Peers
Comparison fields: 5 of 128
- Molecular Biology 1.4k
- Cancer Research 601
- Surgery 398
- Biomaterials 378
- Oncology 351
Countries citing papers authored by Liang Jin
This map shows the geographic impact of Liang Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liang Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liang Jin more than expected).
Fields of papers citing papers by Liang Jin
This network shows the impact of papers produced by Liang Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liang Jin. The network helps show where Liang Jin may publish in the future.
Co-authorship network of co-authors of Liang Jin
This figure shows the co-authorship network connecting the top 25 collaborators of Liang Jin. A scholar is included among the top collaborators of Liang Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liang Jin. Liang Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 2 | |
| 3 | 3 | |
| 4 | 5 | |
| 5 | 4 | |
| 6 | 7 | |
| 7 | 5 | |
| 8 | 13 | |
| 9 | 9 | |
| 10 | 29 | |
| 11 | 4 | |
| 12 | 77 | |
| 13 | 50 | |
| 14 | 70 | |
| 15 | 18 | |
| 16 | 15 | |
| 17 | 9 | |
| 18 | 19 | |
| 19 | 12 | |
| 20 | 11 |
About Liang Jin
Liang Jin is a scholar working on Biomaterials, Cancer Research and Pharmacology, having authored 93 papers that have together received 2.7k indexed citations. Recurring topics across this work include Pancreatic function and diabetes (14 papers), Diabetes and associated disorders (8 papers) and MicroRNA in disease regulation (8 papers). The work is most often cited by research in Cancer Research (601 citations), Biomaterials (378 citations) and Molecular Biology (1.4k citations). Liang Jin has collaborated with scholars based in China, United States and Spain. Frequent co-authors include Yi Pan, Tingting Tang, Guangyin Yuan, Yanfeng Zhang, Tiansong Xia, Ziwei Song, Jun Liao, Xue Wang, Jing Li and Jing Shang. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Communications and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.